Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIN457 vs placebo for posterior or panuveitis in Behçet's disease
2009-011237-27Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of secukinumab in posterior uveitis, Behçet's disease-associated panuveitis, sponsored by Novartis. Started Jul 2009; status: completed.
02
Drugs
secukinumab
03
Conditions
posterior uveitisBehçet's disease-associated panuveitis
Beyond the preview
Go deeper on 2009-011237-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011237-27.